Novel Compounds with Promising IDO1 Inhibitory Activity As New Cancer Drug Candidates: Derivatives Of N, N'-diphenylurea Linked With 1,2,3-triazole
Die Pharmazie · 01.04.2023 · 78 (1-4)
DOI: 10.31083/ph.2023.2552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Die Pharmazie, online erschienen am 01.04.2023. Verfasst von Bin Sun und 8 weiteren Autor:innen.
Abstract (Originalsprache)
To explore potential indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors, we designed a series of compounds incorporating urea and 1,2,3-triazole structures. IDO1 enzymatic activity experiments with the synthesized compounds were used to verify their molecular-level activity; for instance, the half maximal inhibitory concentration value of compound 3c was 0.07 μM. Our research has yielded a series of novel IDO1 inhibitors which may be beneficial in the development of drugs targeting IDO1 for cancer treatment.
Zitieren
APA
Sun, B., Liu, X., Sun, X., Zhou, Y., Gong, X., Mao, L., Shi, W., Deng, P., & Shi, L. (2023). Novel Compounds with Promising IDO1 Inhibitory Activity As New Cancer Drug Candidates: Derivatives Of N, N'-diphenylurea Linked With 1,2,3-triazole. Die Pharmazie, 78(1-4). https://doi.org/10.31083/ph.2023.2552
Vancouver
Sun B, Liu X, Sun X, Zhou Y, Gong X, Mao L, et al. Novel Compounds with Promising IDO1 Inhibitory Activity As New Cancer Drug Candidates: Derivatives Of N, N'-diphenylurea Linked With 1,2,3-triazole. Die Pharmazie. 2023;78(1-4). doi:10.31083/ph.2023.2552
BibTeX
@article{Sun2023,
author = {Sun, Bin and Liu, Xiaofei and Sun, Xiuwei and Zhou, Yingjie and Gong, Xiaoqing and Mao, Longfei and Shi, Weichen and Deng, Peng and Shi, Lin},
title = {Novel Compounds with Promising IDO1 Inhibitory Activity As New Cancer Drug Candidates: Derivatives Of N, N'-diphenylurea Linked With 1,2,3-triazole},
journal = {Die Pharmazie},
year = {2023},
volume = {78},
number = {1-4},
doi = {10.31083/ph.2023.2552}
}
EUVIMED